Connection

Andrew Kraft to Indazoles

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Indazoles.
Andrew Kraft
Connection Strength
0.795
Indazoles
  1. A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer. 2021 03 15; 127(6):894-904.
    View in: PubMed
    Score: 0.743
  2. OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer. 2022 10 01; 128(19):3516-3522.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.